Wordt geladen...
Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain
BACKGROUND: Cebranopadol (a.k.a. GRT-6005) is a dually acting nociceptin/orphanin FQ and opioid receptor agonist that has been recently developed in Phase 2 clinical trials for painful diabetic neuropathy or cancer pain. It also showed analgesic properties in various rat models of pain and had a bet...
Bewaard in:
| Gepubliceerd in: | Inflammopharmacology |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer International Publishing
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5859690/ https://ncbi.nlm.nih.gov/pubmed/29071457 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10787-017-0405-5 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|